{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:49:57Z","timestamp":1776196197196,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.numecd.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:08Z","timestamp":1399248008000},"page":"1035-1042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: An observational study"],"prefix":"10.1016","volume":"24","author":[{"given":"M.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dimeski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9456","key":"10.1016\/j.numecd.2014.04.006_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(05)17789-7","article-title":"Chronic kidney disease: the global challenge","volume":"365","author":"El Nahas","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.numecd.2014.04.006_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.13172\/2053-0293-1-2-763","article-title":"Indoxyl sulphate and p-cresyl sulphate: therapeutically modifiable nephrovascular toxins","volume":"1","author":"Rossi","year":"2013","journal-title":"OA Nephrol"},{"issue":"2","key":"10.1016\/j.numecd.2014.04.006_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.numecd.2014.04.006_bib4","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","article-title":"Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells","volume":"63","author":"Motojima","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.numecd.2014.04.006_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.numecd.2014.04.006_bib6","doi-asserted-by":"crossref","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.numecd.2014.04.006_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.numecd.2014.04.006_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.numecd.2014.04.006_bib9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","article-title":"Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients-a prospective cohort study","volume":"27","author":"Wu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.numecd.2014.04.006_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","article-title":"Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease","volume":"43","author":"Lin","year":"2012","journal-title":"Arch Med Res"},{"key":"10.1016\/j.numecd.2014.04.006_bib11","first-page":"S188","article-title":"Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study","volume":"63","author":"Owada","year":"1997","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1016\/j.numecd.2014.04.006_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2215\/CJN.05340610","article-title":"Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress","volume":"6","author":"Yu","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.numecd.2014.04.006_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002489900020","article-title":"Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine","volume":"33","author":"Smith","year":"1997","journal-title":"Microb Ecol"},{"issue":"2","key":"10.1016\/j.numecd.2014.04.006_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.numecd.2014.04.006_bib15","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.2215\/CJN.00300113","article-title":"Renal clearance and intestinal generation of p-cresyl sulfate and indoxyl sulfate in CKD","volume":"8","author":"Poesen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.numecd.2014.04.006_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcla.20456","article-title":"p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease","volume":"25","author":"Lin","year":"2011","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.numecd.2014.04.006_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2369-14-134","article-title":"Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators","volume":"14","author":"Melamed","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.numecd.2014.04.006_bib18","unstructured":"Schulman G, Berl T, Beck GJ, remuzzi G, Ritz E, Univ V. EPPIC (Evaluating Prevention of Progression in Chronic Kidney Disease): results from 2 phase III, randomized, placebo-controlled, double-blind trials of AST-120 in Adults with CKD ASN 2012; A: PO1106."},{"issue":"3","key":"10.1016\/j.numecd.2014.04.006_bib19","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ahj.2005.06.017","article-title":"Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function","volume":"151","author":"Isbel","year":"2006","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.numecd.2014.04.006_bib20","article-title":"KDIGO 2012 clinial practice guidelines for the evaluation and management of chronic kidney disease","volume":"3","author":"KDIGO","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2014.04.006_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cca.2013.02.008","article-title":"Reference ranges and biological variation of free and total serum indoxyl- and p-cresyl sulphate measured with a rapid UPLC fluorescence detection method","volume":"419","author":"Pretorius","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.numecd.2014.04.006_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ndt\/gfr397","article-title":"Multimodality vascular imaging in CKD: divergence of risk between measured parameters","volume":"27","author":"Petchey","year":"2012","journal-title":"Nephrol Dial Transplant: Off Pub Eur Dial Transplant Assoc \u2013 Eur Renal Assoc"},{"issue":"6052","key":"10.1016\/j.numecd.2014.04.006_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.numecd.2014.04.006_bib24","first-page":"S23","article-title":"The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients","volume":"62","author":"Niwa","year":"1997","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1016\/j.numecd.2014.04.006_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.ajkd.2005.12.036","article-title":"A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD","volume":"47","author":"Schulman","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.numecd.2014.04.006_bib26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.numecd.2014.04.006_bib27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.112.045617","article-title":"Interaction between two sulfate conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin","volume":"40","author":"Watanabe","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.numecd.2014.04.006_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.numecd.2014.04.006_bib29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1253\/circj.CJ-12-0715","article-title":"Association between indoxyl sulfate and cardiac dysfunction and prognosis in patients with dilated cardiomyopathy","volume":"77","author":"Shimazu","year":"2013","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.numecd.2014.04.006_bib30","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.25011\/cim.v36i1.19404","article-title":"Levels of indoxyl sulfate are associated with severity of coronary atherosclerosis","volume":"36","author":"Hsu","year":"2013","journal-title":"Clin Invest Med"},{"issue":"2","key":"10.1016\/j.numecd.2014.04.006_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2012.06.094","article-title":"Indoxyl sulfate, a uremic toxin, and carotid intima-media thickness in patients with coronary artery disease","volume":"163","author":"Sato","year":"2013","journal-title":"Int J Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T03:07:54Z","timestamp":1565406474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475314001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0939475314001380"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2014.04.006","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: An observational study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}